Clinical Trials Logo

Clinical Trial Summary

Bleeding after Mohs micrographic surgery for skin cancer is a low risk complication that can occur. This study aims to determine the effect of a drug, often used to reduce bleeding, called tranexamic acid when applied topically to the skin wound after surgery.


Clinical Trial Description

To perform a prospective randomized controlled trial to determine the hemostatic effect of TXA soaked gauze (intervention) versus normal saline soaked gauze (control) when applied to granulating defects in the setting of Mohs micrographic surgery. Patients meeting inclusion criteria will be randomized into two arms once enrolled in the study on the day of their Mohs micrographic surgery (MMS). One arm will serve as the control group and will receive normal saline soaked telfa pads to the wound bed upon completion of MMS. A second arm will receive TXA 25mg/ml at a volume of 1ml/cm2 soaked telfa pads to wound bed upon completion of MMS. In both arms, the telfa pads will have a standard pressure dressing placed overtop. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04541303
Study type Interventional
Source University of Missouri-Columbia
Contact Brianna Castillo, MD
Phone 5738824800
Email bch4b@health.missouri.edu
Status Recruiting
Phase Early Phase 1
Start date October 8, 2020
Completion date December 2021